首页> 外文期刊>International journal of infectious diseases : >Immunogenicity of Novel Consensus-Based DNA Vaccines Against Chikungunya Virus
【24h】

Immunogenicity of Novel Consensus-Based DNA Vaccines Against Chikungunya Virus

机译:基于共识的新型DNA疫苗对基孔肯雅病毒的免疫原性

获取原文
获取外文期刊封面目录资料

摘要

CHIKV is an emerging arbovirus and is an important human pathogen that causes a syndrome characterized by fever, headache, rash, nausea, vomiting, myalgia, arthralgia and occasionally neurological manifestations such as acute limb weakness. It is also associated with a fatal haemorrhagic condition. CHIKV is geographically distributed from Africa through Southeast Asia and South America, and its transmission to humans is mainly through Aedes species mosquitoes. The frequency of recent epidemics in the Indian Ocean islands suggests that something else was carrying the virus, as Aedes aegypti are not found there.
机译:CHIKV是一种新兴的虫媒病毒,是一种重要的人类病原体,可导致以发烧,头痛,皮疹,恶心,呕吐,肌痛,关节痛以及偶尔的神经系统表现(例如急性肢体无力)为特征的综合症。它还与致命的出血病相关。 CHIKV的地理分布是从非洲通过东南亚和南美进行的,其传播给人类的主要途径是伊蚊。印度洋诸岛最近的流行频率表明,还有其他某种病毒携带该病毒,因为那里没有发现埃及伊蚊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号